Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
CKD progression
GFR decline
Urine osmolality
biomarker
chronic kidney disease (CKD)
end-stage renal disease (ESRD)
glomerular filtration rate (GFR)
measured GFR (mGFR)
prognostic factor
tubular damage
urine concentration ability
Journal
American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
05
06
2018
accepted:
01
12
2018
pubmed:
20
2
2019
medline:
1
2
2020
entrez:
20
2
2019
Statut:
ppublish
Résumé
Chronic kidney disease (CKD) characterized by decreased glomerular filtration rate (GFR) is often accompanied by various degrees of impaired tubular function in the cortex and medulla. Assessment of tubular function may therefore be useful in establishing the severity of kidney disease and identifying those at greater risk for CKD progression. We explored reductions in urinary concentrating ability, a well-known feature of CKD, as a risk factor for GFR decline and end-stage renal disease (ESRD). Prospective longitudinal cohort study. 2,084 adult patients with CKD stages 1 to 4 from the French NephroTest Cohort Study. Fasting urinary osmolality measured using delta cryoscopy. ESRD, mortality before ESRD, and measured GFR (mGFR) assessed using Cause-specific hazards models were fit to estimate crude and adjusted associations of urinary osmolality with ESRD and death before ESRD. Linear mixed models with random intercepts were fit to evaluate the association of urinary osmolality with slope of decline in mGFR. At baseline, mean age was 58.7±15.2 (SD) years with a median mGFR of 40.2 (IQR, 29.1-54.5) mL/min/1.73m Fasting was self-reported. Fasting urinary osmolality may be a useful tool, in addition to GFR and albuminuria, for assessing nonglomerular damage in patients with CKD who are at higher risk for CKD progression.
Identifiants
pubmed: 30777634
pii: S0272-6386(19)30004-6
doi: 10.1053/j.ajkd.2018.12.024
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
596-604Investigateurs
Marine Livrozet
(M)
Emmanuel Letavernier
(E)
Pierre Ronco
(P)
Hafedh Fessi
(H)
Emmanuelle Vidal-Petiot
(E)
Eric Daugas
(E)
Caroline du Halgouet
(C)
Renaud de La Faille
(R)
Gerard Maruani
(G)
Marion Vallet
(M)
Laurence Nicolet-Barousse
(L)
Alexandre Karras
(A)
Christian Jacquot
(C)
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : ErratumIn
Informations de copyright
Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.